FDA inspection

OCB Pharmaceutical SRL: FDA inspection ending Apr 28, 2021

FDA inspection 1166214 · Voluntary Action Indicated (VAI) · Canovelles

Key facts

Inspection ID 1166214
Firm OCB Pharmaceutical SRL
FEI number 3010164271
Address Calle Carles Buhigas, Pol. Industrial Can Castells 5a
City Canovelles
Country Spain
Fiscal year 2021
Inspection end date Apr 28, 2021
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections